Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Crossing Of Coronary Artery Cto

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 15/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (2)
Phase 2 (1)
Phase 4 (1)

Trial Status

Completed3
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT00801710Not ApplicableCompleted

CrossBoss and Stingray Catheter and Entera Guidewire Chronic Total Occlusion (CTO) Study

NCT02379923Not ApplicableCompleted

The Asahi Intecc PTCA Chronic Total Occlusion Study

NCT00886899Phase 2CompletedPrimary

Facilitated Antegrade Steering Technique in Chronic Total Occlusions (FAST-CTOs)

SYFa8bdf0cad0e44cc3916ef6bc6781515cPhase 4Not Yet Recruiting

Evaluation of patients with total coronary occlusions with multimodality image.

Showing all 4 trials

Research Network

Common Treatments

  • Crossing Of Coronary Artery Cto1
  • Bridgepoint Medical System Crossboss Catheter Stingray Catheter Entera Guidewire1
  • Eufilina Venosa 200 Mg Solución Inyectable1
  • Recanalization Of A Coronary Chronic Total Occlusion1
  • Regadenoson1

Active Sponsors

  • BridgePoint Medical2
  • Asahi Intecc USA Inc1
  • Medpace, Inc.1
  • Boston Scientific Corporation1

Top Investigators

Related Conditions

  • Coronary Artery Disease2

Activity Timeline